Tevogen Bio

About:

Clinical stage biotech developing off-the-shelf T cell oncology, virology, and neurology immunotherapeutics, utilizing a patented platform.

Website: https://tevogen.com/

Twitter/X: tevogenbio

Top Investors: HMP Partners, HMP Partners

Description:

A clinical stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology, by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several breakthrough cell and gene therapy platforms.